Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urinary Bladder Neoplasms × Dasatinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17 Breast Neoplasms 15 Leukemia 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Leukemia, Myeloid, Chronic-Phase 10 Recurrence 8 Prostatic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 7 Neoplasm Metastasis 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Melanoma 5 Burkitt Lymphoma 5 Pancreatic Neoplasms 4 Leukemia, Myeloid, Acute 4 Glioblastoma 4 Blast Crisis 4 Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 3 Neoplasms 3 Lymphoma 3 Gliosarcoma 3 Sarcoma 2 Salivary Gland Neoplasms 2 Rhabdomyosarcoma 2 Rectal Neoplasms 2 Polycythemia Vera 2 Oligodendroglioma 2 Multiple Myeloma 2 Lymphoma, Large B-Cell, Diffuse 2

Interventions

Gemcitabine 47 Cisplatin 32 pembrolizumab 28 Paclitaxel 13 Docetaxel 13 avelumab 12 Mitomycin 12 atezolizumab 11 Nivolumab 11 Cystectomy 9 Carboplatin 9 durvalumab 7 Sunitinib 7 apaziquone 6 Doxorubicin 6 BCG Vaccine 6 5-aminolevulinic acid hexyl ester 6 Vinblastine 5 Platinum 5 Methotrexate 5 Magnetic Resonance Spectroscopy 5 Albumin-Bound Paclitaxel 5 Taxes 4 Standard of Care 4 Sorafenib 4 Radiotherapy 4 Radiation 4 Fluorouracil 4 Erlotinib Hydrochloride 4 1,2-diaminocyclohexaneplatinum II citrate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡